SeaStar Medical Holding Corp (ICU)
0.4398
-0.03
(-7.08%)
USD |
NASDAQ |
May 08, 15:10
SeaStar Medical Cash from Operations (Quarterly): -4.485M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.485M |
| September 30, 2023 | -1.337M |
| June 30, 2023 | -2.169M |
| March 31, 2023 | -2.294M |
| December 31, 2022 | -5.302M |
| Date | Value |
|---|---|
| September 30, 2022 | -0.914M |
| June 30, 2022 | -0.991M |
| March 31, 2022 | -0.587M |
| June 30, 2021 | -0.959M |
| March 31, 2021 | -1.70M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.302M
Minimum
Dec 2022
-0.587M
Maximum
Mar 2022
-2.074M
Average
-1.518M
Median
Cash from Operations (Quarterly) Benchmarks
| Nuwellis Inc | -2.754M |
| Ardelyx Inc | -35.72M |
| Adverum Biotechnologies Inc | -21.33M |
| Aquestive Therapeutics Inc | -4.942M |
| Vir Biotechnology Inc | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 4.588M |
| Free Cash Flow | -10.28M |
| Free Cash Flow Per Share (Quarterly) | -0.0942 |
| Free Cash Flow Yield | -97.82% |